Status: Recruiting
Dapagliflozin Delays the Loss of Renal Function in Peritoneal Dialysis Patients
This study aims to explore the role of dagliflozin in preserving the residual renal function(RRF) in peritoneal dialysis (PD) patients.
Participants needed: 70
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Sichuan Academy of Medical SciencesUpdated: May 3, 2024Locations: 1
Eligibility criteria
Patients with PD duration between 1 month and 3 months. [+5]
Pregnant and lactating women. [+13]